These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28059968)

  • 1. Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis.
    Satoi S; Fujii T; Yanagimoto H; Motoi F; Kurata M; Takahara N; Yamada S; Yamamoto T; Mizuma M; Honda G; Isayama H; Unno M; Kodera Y; Ishigami H; Kon M
    Ann Surg; 2017 Feb; 265(2):397-401. PubMed ID: 28059968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.
    Yamada S; Fujii T; Yamamoto T; Takami H; Yoshioka I; Yamaki S; Sonohara F; Shibuya K; Motoi F; Hirano S; Murakami Y; Inoue H; Hayashi M; Murotani K; Kitayama J; Ishikawa H; Kodera Y; Sekimoto M; Satoi S
    Br J Surg; 2020 Dec; 107(13):1811-1817. PubMed ID: 32638367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit of intravenous and intraperitoneal paclitaxel with S-1 in pancreatic ductal adenocarcinoma patients with peritoneal metastasis: a retrospective study in a single institution.
    Satoi S; Yanagimoto H; Yamamoto T; Hirooka S; Yamaki S; Kosaka H; Inoue K; Hashimoto Y; Matsui Y; Kon M
    J Hepatobiliary Pancreat Sci; 2017 May; 24(5):289-296. PubMed ID: 28301088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
    Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
    Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
    Ishigami H; Kitayama J; Kaisaki S; Hidemura A; Kato M; Otani K; Kamei T; Soma D; Miyato H; Yamashita H; Nagawa H
    Ann Oncol; 2010 Jan; 21(1):67-70. PubMed ID: 19605503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites.
    Takahara N; Isayama H; Nakai Y; Ishigami H; Satoi S; Mizuno S; Kogure H; Matsubara S; Yamamoto N; Yamaguchi H; Tada M; Kitayama J; Watanabe T; Koike K
    Invest New Drugs; 2016 Oct; 34(5):636-42. PubMed ID: 27339809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
    Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.
    Yamaguchi H; Satoh Y; Ishigami H; Kurihara M; Yatomi Y; Kitayama J
    Ann Surg Oncol; 2017 Oct; 24(11):3345-3352. PubMed ID: 28726078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis.
    Imano M; Peng YF; Itoh T; Nishikawa M; Satou T; Yasuda A; Inoue K; Kato H; Shinkai M; Tsubaki M; Yasuda T; Imamoto H; Nishida S; Furukawa H; Takeyama Y; Okuno K; Shiozaki H
    Anticancer Res; 2012 Sep; 32(9):4071-5. PubMed ID: 22993363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial.
    Kodera Y; Takahashi N; Yoshikawa T; Takiguchi N; Fujitani K; Ito Y; Miyamoto K; Takayama O; Imano M; Kobayashi D; Miyashita Y; Morita S; Sakamoto J
    Gastric Cancer; 2017 Jan; 20(1):190-199. PubMed ID: 26879545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer.
    Tamura S; Miki H; Nakata K; Takiuchi D; Okada K; Nakahira S; Okamura S; Sugimoto K; Tomita N; Takatsuka Y
    Gastric Cancer; 2007; 10(4):251-5. PubMed ID: 18095081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer.
    Ishigami H; Kitayama J; Otani K; Kamei T; Soma D; Miyato H; Yamashita H; Hidemura A; Kaisaki S; Nagawa H
    Oncology; 2009; 76(5):311-4. PubMed ID: 19299904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancer.
    Peng YF; Imano M; Itoh T; Satoh T; Chiba Y; Imamoto H; Tsubaki M; Nishida S; Yasuda T; Furukawa H
    J Surg Oncol; 2015 Jun; 111(8):1041-6. PubMed ID: 26060133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of intraperitoneal administration of paclitaxel and oral S-1 for patients with peritoneal metastasis due to advanced gastric cancer.
    Tamura S; Miki H; Okada K; Miyake T; Yoshimura M; Suzuki R; Nakahira S; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
    Int J Clin Oncol; 2008 Dec; 13(6):536-40. PubMed ID: 19093182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for malignant ascites due to advanced gastric cancer.
    Kitayama J; Ishigami H; Kaisaki S; Hidemura A; Kato M; Otani K; Kamei T; Soma D; Miyato H; Yamashita H; Nagawa H
    Oncology; 2010; 78(1):40-6. PubMed ID: 20197706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of gastric cancer with peritoneal dissemination responding to combination chemotherapy with oral fluoropyrimidine and weekly paclitaxel].
    Tokunaga Y; Sasaki H; Saitou T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):999-1001. PubMed ID: 18633233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis.
    Kobayashi D; Ishigami H; Kanda M; Tanaka C; Yamaguchi H; Kitayama J; Kodera Y
    Oncology; 2020; 98(1):48-52. PubMed ID: 31487733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407).
    Nishina T; Boku N; Gotoh M; Shimada Y; Hamamoto Y; Yasui H; Yamaguchi K; Kawai H; Nakayama N; Amagai K; Mizusawa J; Nakamura K; Shirao K; Ohtsu A;
    Gastric Cancer; 2016 Jul; 19(3):902-10. PubMed ID: 26386560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases.
    Shi M; Yang Z; Lu S; Liu W; Ni Z; Yao X; Hua Z; Feng R; Zheng Y; Wang Z; Sah BK; Chen M; Zhu Z; He C; Li C; Zhang J; Yan C; Yan M; Zhu Z
    BMC Cancer; 2021 Dec; 21(1):1344. PubMed ID: 34922478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.